Article
Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis.
Scientific reports - 24 Jan 2017
Lanz Tobias V, Williams Sarah K, Stojic Aleksandar, Iwantscheff Simeon, Sonner Jana K, Grabitz Carl, Becker Simon, Böhler Laura-Inés, Mohapatra Soumya R, Sahm Felix, Küblbeck Günter, Nakamura Toshikazu, Funakoshi Hiroshi, Opitz Christiane A, Wick Wolfgang, Diem Ricarda, Platten Michael
Abstract excerpt
The catabolism of tryptophan to immunosuppressive and neuroactive kynurenines is a key metabolic pathway regulating immune responses and neurotoxicity. The rate-limiting step is controlled by indoleamine-2,3-dioxygenase (IDO) and tryptophan-2,3-dioxygenase (TDO). IDO is expressed in antigen presenting cells during immune reactions, hepatic TDO regulates blood homeostasis of tryptophan and neuronal TDO influences...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
